Skip to main content
. Author manuscript; available in PMC: 2018 Nov 15.
Published in final edited form as: Eur J Pharm Sci. 2017 Aug 1;109:78–85. doi: 10.1016/j.ejps.2017.07.031

TABLE 1.

Demographic and baseline characteristics of the subjects enrolled in Experiment 1 of the clinical study.

Placebo
0-mg
(n=12)		 GET 73
10-mg
(n=6)		 GET 73
30-mg
(n=6)		 GET 73
100-mg
(n=6)
Age (years) 35.8 (11.7) 25.3 (6.3) 41.2 (11.8) 29.8 (10.4)
Weight (kg) 77.8 (10.7) 78.8 (12.7) 80.0 (10.1) 83.9 (10.2)
Height (cm) 179.5 (4.0) 179.5 (6.4) 178.7 (3.9) 177.8 (5.8)
BMI (kg/m2) 24.2 (3.5) 24.4 (3.1) 25 (2.6) 26.4 (1.7)
Placebo
0-mg
(n=12)		 GET 73
300-mg
(n=6)		 GET 73
450-mg
(n=6)		 GET 73
600-mg
(n=6)
Age (years) 35.8 (11.7) 32.3 (14.3) 36 (8.5) 42.2 (9.0)
Weight (kg) 77.8 (10.7) 80.3(6.2) 84.6 (7.3) 87.8 (3.8)
Height (cm) 179.5 (4.0) 180.3 (4.3) 179.3 (8.3) 180.8 (1.6)
BMI (kg/m2) 24.2 (3.5) 24.8 (2.5) 26.4 (2.5) 26.9 (1.3)

Results are reported as M and (SD); BMI: Body Mass Index